TGF-β-Elicited Induction of Tissue Inhibitor of Metalloproteinases (TIMP)-3 Expression in Fibroblasts Involves Complex Interplay between Smad3, p38α, and ERK1/2

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Leivonen, Suvi Katri ^a,b,d   Lazaridis, Konstantinos ^c   Decock, Julie ^c   Chantry, Andrew ^c   Edwards, Dylan R ^c   Kähäri, Veli Matti ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; FIBROBLASTS; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSFORMING GROWTH FACTOR BETA;

EID: 84874575262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057474     Document Type: Article

References (55)

1. Folgueras AR, Pendas AM, Sanchez LM, López-Otín C, (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424.
2. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
3. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
4. Brew K, Nagase H, (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803: 55-71.
5. Baker AH, Edwards DR, Murphy G, (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727.
6. Ahonen M, Baker AH, Kähäri V-M, (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58: 2310-2315.
7. Baker AH, Zaltsman AB, George SJ, Newby AC, (1998) Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101: 1478-1487.
8. Ahonen M, Ala-aho R, Baker AH, George SJ, Grenman R, et al. (2002) Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol Ther 5: 705-715.
9. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, et al. (2003) Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 22: 2121-2134.
10. Kallio JP, Hopkins-Donaldson S, Baker AH, Kähäri V-M, (2011) Int J Cancer. 128: 991-996.
11. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR, (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352-9360.
12. Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C, et al. (1996) Differential effects of transforming growth factor-β1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 31: 207-223.
13. Su S, Dehnade F, Zafarullah M, (1996) Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-β and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol 15: 1039-1048.
14. Qureshi HY, Ricci G, Zafarullah M, (2008) Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor β in human chondrocytes. Biochim Biophys Acta 1783: 1605-1612.
15. Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, et al. (1998) Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 110: 416-421.
16. Schiller M, Javelaud D, Mauviel A, (2004) TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35: 83-92.
17. ten Dijke P, Hill CS, (2004) New insights into TGF-β-Smad signalling. Trends Biochem Sci 29: 265-273.
18. Uria JA, Jimenez MG, Balbin M, Freije JM, López-Otín C, (1998) Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 273: 9769-9777.
19. Yuan W, Varga J, (2001) Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves smad3. J Biol Chem 276: 38502-38510.
20. Leivonen S-K, Kähäri V-M, (2007) Transforming growth factor-β signaling in cancer invasion and metastasis. Int J Cancer 121: 2119-2124.
21. Ravanti L, Häkkinen L, Larjava H, Saarialho-Kere U, Foschi M, et al. (1999) Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 274: 37292-37300.
22. Dennler S, Prunier C, Ferrand N, Gauthier JM, Atfi A, (2000) c-Jun inhibits transforming growth factor β-mediated transcription by repressing Smad3 transcriptional activity. J Biol Chem 275: 28858-28865.
23. Hayashida T, Decaestecker M, Schnaper HW, (2003) Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 17: 1576-1578.
24. Leivonen S-K, Ala-aho R, Koli K, Grenman R, Peltonen J, et al. (2006) Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 25: 2588-2600.
25. Leivonen S-K, Chantry A, Häkkinen L, Han J, Kähäri V-M, (2002) Smad3 mediates transforming growth factor-β-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 277: 46338-46346.
26. Leivonen S-K, Häkkinen L, Liu D, Kähäri V-M, (2005) Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-β-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 124: 1162-1169.
27. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, et al. (2002) Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J 21: 6473-6482.
28. Ungefroren H, Lenschow W, Chen WB, Fändrich F, Kalthoff H, (2003) Regulation of biglycan gene expression by transforming growth factor-β requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling. J Biol Chem 278: 11041-11049.
29. Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F, (2005) Transforming growth factor-β (TGF-β) type I receptor/ALK5-dependent activation of the GADD45β gene mediates the induction of biglycan expression by TGF-β. J Biol Chem 280: 2644-2652.
30. Sirard C, Kim S, Mirtsos C, Tadich P, Hoodless PA, et al. (2000) Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor β-related signaling. J Biol Chem 275: 2063-2070.
31. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, et al. (1999) Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10: 3801-3813.
32. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, et al. (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J Biol Chem 275: 29244-29256.
33. Wang Y, Su B, Sah VP, Brown JH, Han J, et al. (1998) Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 273: 5423-5426.
34. Foschi M, Chari S, Dunn MJ, Sorokin A, (1997) Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 16: 6439-6451.
35. Wilkinson GW, Akrigg A, (1992) Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20: 2233-2239.
36. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, et al. (1988) Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem 263: 3111-3115.
37. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, et al. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13: 1431-1442.
38. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, et al. (2002) Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364: 89-99.
39. Kähäri VM, Chen YQ, Su MW, Ramirez F, Uitto J, (1990) Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J Clin Invest 86: 1489-1495.
40. Kähäri VM, Olsen DR, Rhudy RW, Carrillo P, Chen YQ, et al. (1992) Transforming growth factor-β up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest 66: 580-8.
41. Ravanti L, Toriseva M, Penttinen R, Crombleholme T, Foschi M, et al. (2001) Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor β via p38 mitogen-activated protein kinase. FASEB J 15: 1098-100.
42. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, et al. (2003) The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1. J Biol Chem 278: 10304-10313.
43. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
44. Stroschein SL, Wang W, Luo K, (1999) Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced smad-dependent transcriptional activation. J Biol Chem 274: 9431-9441.
45. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, et al. (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad 3. J Invest Dermatol 112: 49-57.
46. Vindevoghel L, Kon A, Lechleider RJ, Uitto J, Roberts AB, et al. (1998) Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β. J Biol Chem 273: 13053-13057.
47. Watanabe H, de Caestecker MP, Yamada Y, (2001) Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276: 14466-14473.
48. Leask A, Abraham DJ, (2004) TGF-β signaling and the fibrotic response. FASEB J 18: 816-2.
49. Gill SE, Huizar I, Bench EM, Sussman SW, Wang Y, et al. (2010) Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol 176: 64-73.
50. Murthy A, Shao YW, Defamie V, Wedeles C, Smookler D, et al. (2012) Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis. J Immunol 188: 2876-83.
51. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA Jr, Topper JN, (1999) MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 274: 8797-8805.
52. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, et al. (1998) Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12: 1587-1592.
53. Sebe A, Leivonen S-K, Fintha A, Masszi A, Rosivall L, et al. (2008) Transforming growth factor-β-induced α-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38β mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation. Nephrol Dial Transplant 23: 1537-45.
54. Rönty MJ, Leivonen S-K, Hinz B, Rachlin A, Otey CA, et al. (2006) Isoform-specific regulation of the actin-organizing protein palladin during TGF-β1-induced myofibroblast differentiation. J Invest Dermatol 126: 2387-2396.
55. Heikkinen PT, Nummela M, Leivonen S-K, Westermarck J, Hill CS, et al. (2010) Hypoxia-activated Smad3-specific dephosphorylation by PP2A. J Biol Chem 285: 3740-9.